Back
Royalty Pharma PLC Vs. Pacira BioSciences Industry Stock Comparison
Sell
38
RPRX
Royalty Pharma PLC
Last Price:
27.86
Seasonality Move:
-2.02%
Buy
56
PCRX
Pacira BioSciences
Last Price:
31.52
Seasonality Move:
7.59%
Sell
38
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $28.21. The Score for RPRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Pacira BioSciences (PCRX)
is a Buy
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $30.08. The Score for PCRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $28.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $30.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 47.19 | Sell |
| Chaikin Money Flow: | -466302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.79 - 28.45) | Buy |
| Bollinger Bands (100): | (27.98 - 30.06) | Sell |
PCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 61.97 | Buy |
| Chaikin Money Flow: | -624096 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.81 - 28.95) | Buy |
| Bollinger Bands (100): | (27.58 - 32.18) | Buy |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.18 | Buy |
| 20-day SMA: | 28.11 | Buy |
| 50-day SMA: | 29.01 | Sell |
| 200-day SMA: | 28.6 | Sell |
| 8-day EMA: | 28.18 | Buy |
| 20-day EMA: | 28.28 | Sell |
| 50-day EMA: | 28.68 | Sell |
| 200-day EMA: | 29.65 | Sell |
PCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.15 | Buy |
| 20-day SMA: | 27.5 | Buy |
| 50-day SMA: | 28.36 | Buy |
| 200-day SMA: | 30.78 | Sell |
| 8-day EMA: | 29.37 | Buy |
| 20-day EMA: | 28.34 | Buy |
| 50-day EMA: | 28.41 | Buy |
| 200-day EMA: | 31.57 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.
Royalty Pharma PLC Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pacira BioSciences Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||